Диссертация (1145849), страница 24
Текст из файла (страница 24)
– №. 6. – P. M111. 010744.135. Herrera M.B., Bussolati B., Bruno S., Morando L., Mauriello-Romanazzi G.,Sanavio F., Stamenkovic I., Biancone L., Camussi G. Exogenous mesenchymalstem cells localize to the kidney by means of CD44 following acute tubularinjury //Kidney international.
– 2007. – V. 72. – №. 4. – P. 430-441.136. Hoch A.I., Leach J.K. Concise review: optimizing expansion of bone marrowmesenchymal stem/stromal cells for clinical applications //Stem cellstranslational medicine. – 2014. – P. sctm. 2013-0196.137. Holter W., Kalthoff F.S., Pickl W.F., Ebner C., Majdic O., Kraft D., Knapp W.Transforming growth factor-β inhibits IL-4 and IFNγ production by stimulatedhuman T cells //International immunology.
– 1994. – V. 6. – №. 3. – P. 469-475.138. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I.,Marini F.C., Deans R.J., Krause D.S., Keating A. Clarification of thenomenclature for MSC: The International Society for Cellular Therapy positionstatement //Cytotherapy. – 2005. – V. 7. – №. 5. – P.
393-395.139. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., SinigagliaF., D'Ambrosio D. Unique chemotactic response profile and specific expressionof chemokine receptors CCR4 and CCR8 by CD4+ CD25+ regulatory T cells//The Journal of experimental medicine. – 2001. – V. 194. – №. 6.
– P. 847-854.140. Isa A., Nehlin J.O., Sabir H.J., Andersen T.E., Gaster M., Kassem M., BaringtonT. Impaired cell surface expression of HLA-B antigens on mesenchymal stemcells and muscle cell progenitors //PloS one. – 2010. – V. 5. – №. 5. – P.e10900.142141. Ishige I., Nagamura-Inoue T., Honda M.J., Harnprasopwat R., KidoM., Sugimoto M., Nakauchi H., Tojo A. Comparison of mesenchymal stem cellsderived from arterial, venous, and Wharton’s jelly explants of human umbilicalcord //International journal of hematology.
– 2009. – V. 90. – №. 2. – P. 261269.142. Ito Y., Adachi Y., Makino T., Higashiyama H., Fuchizawa T., ShimizuT., Miyawaki T. Expansion of FOXP3-positive CD4+ CD25+ T cells associatedwith disease activity in atopic dermatitis //Annals of Allergy, Asthma &Immunology. – 2009. – V. 103. – №. 2. – P. 160-165.143. Jiang T., Liu W., Lv X., Sun H., Zhang L., Liu Y., Zhang W.J., Cao Y., ZhouG.. Potent in vitro chondrogenesis of CD105 enriched human adipose-derivedstem cells //Biomaterials. – 2010.
– V. 31. – №. 13. – P. 3564-3571.144. Jin H.J., Park S.K., Oh W., Yang Y.S., Kim S.W., Choi S.J. Down-regulation ofCD105 is associated with multi-lineage differentiation in human umbilical cordblood-derived mesenchymal stem cells //Biochemical and biophysical researchcommunications. – 2009. – V.
381. – №. 4. – P. 676-681.145. Jori F.P., Napolitano M.A., Melone M.A., Jori F.P., Napolitano M.A., MeloneM.A., Cipollaro M., Cascino A., Altucci L., Peluso G., Giordano A., GalderisiU. Molecular pathways involved in neural in vitro differentiation of marrowstromal stem cells //Journal of cellular biochemistry. – 2005.
– V. 94. – №. 4. –P. 645-655.146. Jones B.J., McTaggart S.J. Immunosuppression by mesenchymal stromal cells:from culture to clinic //Experimental hematology. – 2008. – Т. 36. – №. 6. – С.733-741.147. Jurisic G., Iolyeva M., Proulx S.T., Halin C., Detmar M.
Thymus cell antigen 1(Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion tolymphatic endothelium //Experimental cell research. – 2010. – V. 316. – №. 17.– P. 2982-2992.148. Kapoor S., Patel S.A., Kartan S., Axelrod D., Capitle E., Rameshwar P.Tolerance-like mediated suppression by mesenchymal stem cells in patients withdust mite allergy–induced asthma //Journal of Allergy and ClinicalImmunology. – 2012. – V. 129. – №.
4. – P. 1094-1101.149. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control ofNF-κB activity //Annual review of immunology. – 2000. – V. 18. – №. 1. – P.621-663.150. Karlsson C., Brantsing C., Egell S., Lindahl A. Notch1, Jagged1, and HES5 areabundantly expressed in osteoarthritis //Cells, tissues, organs. – 2007. – V. 188.– №. 3. – P.
287-298.143151. Kavanagh H., Mahon B.P. Allogeneic mesenchymal stem cells prevent allergicairway inflammation by inducing murine regulatory T cells //Allergy. – 2011. –V. 66. – №. 4. – P. 523-531.152. Kawamoto K., Konno M., Nagano H., Nishikawa S., Tomimaru Y., AkitaH., Hama N., Wada H., Kobayashi S., Eguchi H., Tanemura M., Ito T., DokiY., Mori M., Ishii H. CD90-(Thy-1-) high selection enhances reprogrammingcapacity of murine adipose-derived mesenchymal stem cells //Disease markers.– 2013. – V. 35.
– №. 5. – P. 573-579.153. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity:update on Toll-like receptors //Nature immunology. – 2010. – V. 11. – №. 5. –P. 373-384.154. Kim D.W., Staples M., Shinozuka K., Pantcheva P., Kang S.D., Borlongan C.V.Wharton’s jelly-derived mesenchymal stem cells: phenotypic characterizationand optimizing their therapeutic potential for clinical applications //Internationaljournal of molecular sciences.
– 2013. – V. 14. – №. 6. – P. 11692-11712.155. Klein S., Kretz C.C., Krammer P.H., Kuhn A. CD127low/-and FoxP3+expression levels characterize different regulatory T cell populations in humanperipheral blood // J. Invest Dermatol. – 2010. – V. 129. – P. S21-S21.156. Klyushnenkova E., Mosca J.D., Zernetkina V., Majumdar M.K., BeggsK.J., Simonetti D.W., Deans R.J., McIntosh K.R. T cell responses to allogeneichuman mesenchymal stem cells: immunogenicity, tolerance, and suppression//Journal of biomedical science.
– 2005. – V. 12. – №. 1. – P. 47-57.157. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F.Bone marrow mesenchymal stem cells inhibit the response of naïve and memoryantigen-specific T cells to their cognate peptide // Blood. – 2003. – V. 101. – P.3722-3729.158. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A. SantarlasciV., Mazzinghi B., Pizzolo G.,Vinante F.,Romagnani P., MaggiE., Romagnani S., Annunziato F.
Role for Interferon-γ in theImmunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells//Stem cells. – 2006. – V. 24. – №. 2. – P. 386-398.159. Kronsteiner B., Wolbank S., Peterbauer A., Hackl C., Redl H., van GriensvenM., Gabriel C. Human mesenchymal stem cells from adipose tissue and amnioninfluence T-cells depending on stimulation method and presence of otherimmune cells //Stem cells and development. – 2011. – V. 20.
– №. 12. – P.2115-2126.144160. Kubo M., Motomura Y. Transcriptional regulation of the anti-inflammatorycytokine IL-10 in acquired immune cells //Frontiers in immunology. – 2012. –V. 3.161. Kunz B., Oranje A.P., Labrèze L., Stalder J.F., Ring J., Taïeb A. Clinicalvalidation and guidelines for the SCORAD index: consensus report of theEuropean Task Force on Atopic Dermatitis //Dermatology. – 1997. – V.
195. –№. 1. – P. 10-19.162. Laffón A., Garcia-Vicuna R., Humbria A., Postigo A.A., Corbi A.L., deLandazuri M.O., Sanchez-Madrid F. Upregulated expression and function ofVLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis//Journal of Clinical Investigation. – 1991. – V. 88.
– №. 2. – P. 546.163. Lalu M.M., McIntyre L., Pugliese C., Fergusson D., Winston B.W., MarshallJ.C., Granton J., Stewart D.J. Safety of cell therapy with mesenchymal stromalcells (SafeCell): a systematic review and meta-analysis of clinical trials //PLOSone.
– 2012. – V. 7. – №. 10. – P. e47559.164. Laranjeira P., Pedrosa M., Pedreiro S., Gomes J., Martinho A., AntunesB., Ribeiro T., Santos F., Trindade H., Paiva A. Effect of human bone marrowmesenchymal stromal cells on cytokine production by peripheral blood naive,memory and effector T cells //Stem cell research & therapy. – 2015. – V. 6. –№. 1.
– P. 3.165. Le Blanc K., Rasmusson I., Gotherstrom C., Seidel C., Sundberg B., Sundin M.,Rosendahl K., Tammik C., Ringden O. Mesenchymal stem cells inhibit theexpression of CD25 (interleukin_2 receptor) and CD38 on phytohaemagglutininactivated lymphocytes // Scandinavian journal of immunology. – 2004. – V. 60.– №. 3. – P.
307-315.166. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringdén O. HLAexpression and immunologic propertiesof differentiated and undifferentiatedmesenchymal stem cells //Experimental hematology. – 2003. – V. 31. – №. 10. –P. 890-896.167. Levi B., Wan D.C., Glotzbach J.P., Hyun J., Januszyk M., Montoro D., SorkinM., James A.W., Nelson E.R., Li S., Quarto N., Lee M., Gurtner G.C., LongakerM.T. CD105 protein depletion enhances human adipose-derived stromal cellosteogenesis through reduction of transforming growth factor β1 (TGFβ1)signaling //Journal of Biological Chemistry. – 2011.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
